Ramdas Borhade: IL-17, Endothelial Activation and Thrombosis Prediction in Cancer
Ramdas Borhade, Deputy General Manager at Murali Krishna Pharma PVT LTD, shared on LinkedIn about a recent article by Dimitra Karagkouni et al, published in Science Translational Medicine, adding:
”Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation | Science Translational Medicine.”
Title: Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation
Authors: Dimitra Karagkouni, Marisa A. Brake, Rushad Patell, Anna Falanga, Marina Marchetti, Laura Russo, Simon Mantha, Donna Neuberg, Thita Chiasakul, Marc Carrier, Philip S. Wells, Robert E. Gerszten, Robert Flaumenhaft, Daniel Hui, Ioannis S. Vlachos, Sol Schulman, Jeffrey I. Zwicker
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 2, 2026, 22:15Micheline Mambue: A Case of Early Stent Thrombosis Successfully Managed With Repeat Angioplasty
-
Nov 2, 2026, 22:12Annie Bauzon: How the Body Produces Millions of Blood Cells Every Day
-
Nov 2, 2026, 22:11Anna Supernat: Does Leukocyte-Associated RNA Retention Affect Platelet-Based Cancer Classification?
-
Nov 2, 2026, 22:07Aabha Divya: Late Biatrial Thrombosis 31 Years After Heart Transplantation
-
Nov 2, 2026, 22:01Sakditad Saowapa: Anticoagulant Pharmacology and the Pursuit of Effective Therapy With Less Bleeding
-
Nov 2, 2026, 21:55Lucio D’Anna: Can Inflammatory Biomarkers Identify Residual Risk in Atrial Fibrillation?
-
Nov 2, 2026, 21:54Dawood Findakly: VTE Prophylaxis during Pregnancy
-
Nov 2, 2026, 21:52N. Mariana S. Vasquez: Five Rules That Help Identify the Cause of Hemolytic Anemia
-
Nov 2, 2026, 21:52Rob Maloney: Working Together to Strengthen Bleeding Disorders Care in the Dominican Republic